101829-0 |
Tetrazepam |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Tetrazepam [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
101829-0 |
|
|
|
|
Both |
|
|
|
0 |
Tetrazepam SerPl-mCnc |
|
|
|
N |
|
C9H8N2; Clinoxan; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Musaril; Myolastan; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tetrazepamum |
2.75 |
2.75 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
10183-2 |
Hospital discharge medications |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Hospital discharge medications Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
10183-2 |
|
|
|
|
|
|
|
|
0 |
Hospital discharge medications |
|
|
|
|
|
Disch; discharge medication; Discharge meds; Finding; Findings; H+P; H+P.HX; Hosp; Narrative; P prime; Point in time; Random; Report |
2.63 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
101830-8 |
Medazepam |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Medazepam [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
101830-8 |
|
|
|
|
Both |
|
|
|
0 |
Medazepam SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Lerisum; Level; Mass concentration; Medacepun; Megasedan; Nobrium; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.75 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
101831-6 |
Beclomethasone dipropionate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Beclomethasone dipropionate [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
101831-6 |
|
|
|
|
Both |
|
|
|
0 |
Beclomethasone Dp SerPl-sCnc |
|
|
|
N |
|
Becloforte; Beclomethasone Dp; Beclovent; Beconase; Chemistry; Level; Pl; Plasma; Plsm; Point in time; Pulmicort; QNT; Quan; Quant; Quantitative; Qvar; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vancenase; Vanceril |
2.76 |
2.75 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
101832-4 |
Betamethasone |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Betamethasone [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101832-4 |
|
|
|
|
Both |
|
|
|
0 |
Betamethasone SerPl-sCnc |
|
|
|
N |
|
Alphatrex; Betatrex; Beta-Val; Celestone; Diprolene; Diprosone; DRUG/TOXICOLOGY; Drugs; Level; Luxiq; Maxivate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101833-2 |
Budesonide |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Budesonide [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101833-2 |
|
|
|
|
Both |
|
|
|
0 |
Budesonide SerPl-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Entocort; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rhinocort; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101834-0 |
Dexamethasone |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Dexamethasone [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101834-0 |
|
|
|
|
Both |
|
|
|
0 |
Dexamethasone SerPl-sCnc |
|
|
|
N |
|
Decadron; Dexameth; Dexone; DRUG/TOXICOLOGY; Drugs; Hexadrol; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101835-7 |
Fludrocortisone |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Fludrocortisone [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101835-7 |
|
|
|
|
Both |
|
|
|
0 |
Fludrocortisone SerPl-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101836-5 |
Flunisolide |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Flunisolide [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101836-5 |
|
|
|
|
Both |
|
|
|
0 |
Flunisolide SerPl-sCnc |
|
|
|
N |
|
AeroBid; Bronalide; DRUG/TOXICOLOGY; Drugs; Level; Nasalide; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rhinalar; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101837-3 |
Fluorometholone |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Fluorometholone [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101837-3 |
|
|
|
|
Both |
|
|
|
0 |
Fluorometholone SerPl-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; FML Forte Liquifilm; FML Liquifilm; FML S.O.P.; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101838-1 |
Fluticasone propionate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Fluticasone propionate [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101838-1 |
|
|
|
|
Both |
|
|
|
0 |
Fluticasone Prop SerPl-sCnc |
|
|
|
N |
|
Cutivate; DRUG/TOXICOLOGY; Drugs; Flonase; Flovent; Level; Pl; Plasma; Plsm; Point in time; Propanoic acid; Propioate; Propioic acid; Propionic acid; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101839-9 |
Megestrol acetate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Megestrol acetate [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101839-9 |
|
|
|
|
Both |
|
|
|
0 |
Megestrol Acetate SerPl-sCnc |
|
|
|
N |
|
Acetic acid; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; Level; Megace; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
10184-0 |
Hospital discharge physical findings |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Hospital discharge physical findings Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
10184-0 |
|
|
|
|
|
|
|
|
0 |
Hospital discharge physical findings |
|
|
|
|
|
Disch; Exam; Examination; Finding; Findings; H+P; H+P.HX; Hosp; Narrative; P prime; Phys find; Point in time; Random; Report |
2.63 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
101840-7 |
Methylprednisolone |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Methylprednisolone [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101840-7 |
|
|
|
|
Both |
|
|
|
0 |
Me-prednisolone SerPl-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; MeP; Me-prednisolone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101841-5 |
prednisoLONE |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
prednisoLONE [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101841-5 |
|
|
|
|
Both |
|
|
|
0 |
prednisoLONE SerPl-sCnc |
|
|
|
N |
|
c424; Deltasone; Depo-Medrol; DRUG/TOXICOLOGY; Drugs; Kenalog; Level; Medrol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Solu-Medrol; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101843-1 |
Triamcinolone |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Triamcinolone [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101843-1 |
|
|
|
|
Both |
|
|
|
0 |
Triamcinolone SerPl-sCnc |
|
|
|
N |
|
Aristocort; Atolone; DRUG/TOXICOLOGY; Drugs; Kenacort; Kenalog; Level; Mycolog II; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101844-9 |
Triamcinolone acetonide |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Triamcinolone acetonide [Moles/volume] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101844-9 |
|
|
|
|
Both |
|
|
|
0 |
Triamcinolone Aceto SerPl-sCnc |
|
|
|
N |
|
Aristocort; Atolone; Azmacort; DRUG/TOXICOLOGY; Drugs; Kenacort; Kenalog; Level; Mycolog II; Nasacort; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101845-6 |
Sweat analysis specialist review |
Imp |
Sweat |
Pt |
Nar |
|
|
ACTIVE |
Sweat analysis specialist review of results |
|
ADD |
DefinitionDescription |
|
|
Interpretation |
|
|
|
|
|
|
CHEM |
|
101845-6 |
|
|
|
|
Observation |
|
|
|
0 |
Sweat analys spec rev |
|
|
|
N |
|
Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Sweat analys spec rev; SWT |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101846-4 |
Beclomethasone dipropionate |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Beclomethasone dipropionate [Moles/volume] in Urine |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101846-4 |
|
|
|
|
Both |
|
|
|
0 |
Beclomethasone Dp Ur-sCnc |
|
|
|
N |
|
Becloforte; Beclomethasone Dp; Beclovent; Beconase; DRUG/TOXICOLOGY; Drugs; Level; Point in time; Pulmicort; QNT; Quan; Quant; Quantitative; Qvar; Random; Substance concentration; UA; UR; Urn; Vancenase; Vanceril |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101847-2 |
Betamethasone |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Betamethasone [Moles/volume] in Urine |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101847-2 |
|
|
|
|
Both |
|
|
|
0 |
Betamethasone Ur-sCnc |
|
|
|
N |
|
Alphatrex; Betatrex; Beta-Val; Celestone; Diprolene; Diprosone; DRUG/TOXICOLOGY; Drugs; Level; Luxiq; Maxivate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101848-0 |
Budesonide |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Budesonide [Moles/volume] in Urine |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101848-0 |
|
|
|
|
Both |
|
|
|
0 |
Budesonide Ur-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Entocort; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Rhinocort; Substance concentration; UA; UR; Urn |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101849-8 |
Dexamethasone |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Dexamethasone [Moles/volume] in Urine |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101849-8 |
|
|
|
|
Both |
|
|
|
0 |
Dexamethasone Ur-sCnc |
|
|
|
N |
|
Decadron; Dexameth; Dexone; DRUG/TOXICOLOGY; Drugs; Hexadrol; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
10185-7 |
Hospital discharge procedures |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Hospital discharge procedures Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
10185-7 |
|
|
|
|
|
|
|
|
0 |
Hospital discharge procedures |
|
|
|
|
|
Disch; Finding; Findings; H+P; H+P.HX; Hosp; Narrative; P prime; Point in time; Random; Report |
2.4 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
101850-6 |
Fludrocortisone |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Fludrocortisone [Moles/volume] in Urine |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101850-6 |
|
|
|
|
Both |
|
|
|
0 |
Fludrocortisone Ur-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
101851-4 |
Flunisolide |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Flunisolide [Moles/volume] in Urine |
|
MAJ |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
101851-4 |
|
|
|
|
Both |
|
|
|
0 |
Flunisolide Ur-sCnc |
|
|
|
N |
|
AeroBid; Bronalide; DRUG/TOXICOLOGY; Drugs; Level; Nasalide; Point in time; QNT; Quan; Quant; Quantitative; Random; Rhinalar; Substance concentration; UA; UR; Urn |
2.76 |
2.75 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |